Alx Oncology Holdings Inc. (ALXO)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 98
+0.05
+2.5907%
$
259.71M Market Cap
- P/E Ratio
- Div Yield
1.44M Volume
-3.52 Eps
$ 1.93
Previous Close 
Want to track ALXO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alx Oncology Holdings Inc. (ALXO) Statistics
Valuation metrics
Market Cap 259.71M
Enterprise value 256.14M
Trailing P/E (ttm) -1.77
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 1.99
Enterprise Value/Revenue -
Enterprise Value/EBITDA -3.25
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 639.79K
Average volume (90 days) 814.79K
Price summary
52-Week low 0.96
52-Week high 2.66
Beta -
50-Day moving average 1.98
200-Day moving average 2.01
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.5%
Return on equity -0.9%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.6
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.02
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 9.71%
Book value per share (mrq) 1
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
